The cannabis industry is on edge as it waits to see how the federal government acts. On one side is the slow moving Biden/Harris administration and the Drug Enforcement Administration (DEA) slow walking rescheduling. The DEA is having to wade through overwhelming positive support for fellow agencies and the general public. On the other side, House Speaker Mike Johnson (R-LA) has allowed groups from his party to protest and try to stop the process and issuing statements on the dangers of marijuana. Coupled with a mess in California and a significant drop in investment in the industry as everyone waits the outcome, things are tough. But there are positive signs for NY legal marijuana.
New York was one track to be the biggest single market perhaps in the word in the when they approved recreational marijuana. But a last minute major overhaul of the process a few weeks before it rolled out ended in a massive chaos. January 2023 launch the first legal store, but at year end there were roughly 25 legal dispensaries and ultimately 2,800 illicit ones in the Empire State. While consumers may or may not have known or cared about the legality of where they shopped, they should. The products in the stores are unregulated, which is a strong health issue as ingredients and dosage could vary significantly.
Wana Brands is the largest gummy company in the industry. They are in 20 states, Canada and Puerto Rico and are backed by Canopy and the alcohol giant Constellation Brands. Highly respected, they are the most mainstream major product company in the industry. Entering the New York Market, is a sign things are starting to normalize. NY has closed over 800 illicit stores and is working toward 200 legal ones.
Joe Hodas, President of Wana shared “Wana’s entry in the New York market has been a move that’s been in the works forquite some time. We’ve already established a strong presence in over 20 stores,including The Travel Agency and Housing Works. Orders are rolling in and morelocations will be coming online soon. While our initial focus is on the New York City area,we’re working on expansion into upstate as well. We believe New York will be one of themost important states on the map for us and we are excited to get more products intothe hands of New Yorkers and all those who visit from around the world.”
When asked about why enter the NY market now, Hodas responded.
“Entering the New York market for us was all about timing. In the past, the prevalence of illicit stores in the city made it a challenging environment for a brand like ours. But during my recent visits, I noticed a shift—there’s now a more robust network of regulated, legal stores. We felt it was finally the right moment for Wana Brands to bring our products to New Yorkers. We couldn’t have made this move without our partner, urbanXtracts. Their state-of-the-art manufacturing capabilities and shared commitment to quality have made this launch possible and we’re excited to see what the future will bring.”
“The Travel Agency is thrilled to partner with Wana in this vibrant New York cannabis market, that we’ve helped grow since its launch. Wana is also one of this industry’s pioneers, building their business through consistent products and the exploration of new formats and flavors. We look forward to collaborating with Wana in providing New Yorkers with safe, high-quality cannabis experience.” stated Paul Yau, The Travel Agency, Co-Founder and CEO. One of the larger, legal dispensary brand in NYC.
The actions of the Drug Enforcement Agency (DEA) have caused another delay in marijuana rescheduling – hurting thousands of mom and pop businesses.
While thousands of mom and pop business’s future hangs in the balance, the DEA causes another delay in marijuana rescheduling. Ever since outgoing President Biden delayed starting the process, the Drug Enforcement Administration (DEA) has been dragging their feet on any action. And now they have been ordered to delay to do some questionable actions. While the majority of the public believe it should be legalized and consumer usage has increased, even starting the California sober trend. The DEA and a few members of Congress have fought hard and long against science and public opinion.
In response to a motion filed by cannabis advocates seeking to disqualify the DEA from its role as proponent of the proposed rule to reclassify cannabis, the agency asserted that there was no new evidence presented warranted reconsideration. The advocates, which include notable groups such as Village Farms International and Hemp for Victory, argue that the DEA has stacked the deck against them by selecting participants who oppose the proposed rescheduling from Schedule I to Schedule III. The DEA’s Chief Administrative Law Judge, John Mulrooney granted a request for leave to file an interlocutory appeal—canceling the scheduled January 21 merit-based hearing and staying the proceedings for at least three months. Mulrooney condemned the agency over its “unprecedented and astonishing” defiance of a key directive related to evidence it is seeking to use in upcoming hearings on the Biden administration’s marijuana rescheduling proposal.
The rescheduling process has been complicated by the DEA’s action, including a lack of clarity regarding participants in the hearing for proposed rule change. These complications have led some observers to express skepticism about the likelihood of successful rescheduling in light of recent political developments and the DEA resistance and administrative hurdles.
Despite these setbacks, there is still momentum behind the push to reschedule marijuana. The U.S. Department of Health and Human Services (HHS) has previously concluded that cannabis does not meet the criteria for a Schedule I drug, citing credible scientific support for its medical use. The Food and Drug Administration concurred with the recommendation. This conclusion aligns with growing public sentiment favoring cannabis legalization and reform of its federal status.
As advocates and industry businesses continue to navigate this complex landscape, they remain hopeful ongoing discussions and potential legal challenges will ultimately lead to a more favorable outcome for cannabis rescheduling. The upcoming months will be critical as stakeholders await further developments in this evolving regulatory environment.
Since 2016 cannabis has began slowly legalizing across Canada and the US. Recent research says almost 90% believe it should be legalized. Additionally, California Sober has become a thing, beer sales have flattened and even AARP has joined esteemed medical organizations saying cannabis should be recognized for the health benefits. States are reaping huge tax revenue, but the industry is still struggling without some type of federal recognization. But does marijuana have any sway in the election?
Top concerns of voters include the economy, healthcare, the Supreme Court and abortion, with over 60% of voters considering them very important. And although cannabis consumers use is generally seen more of a democrat habit than republicans, a number of repubicans are fans. Some larger influencers in the industry have been staunch supporter of the GOP nominee. A recent poll found 42% of Republicans and GOP-leaning independent favor legalizing marijuana for both recreational and medical compared with 72% of Democrats. Florida governor Ron DeSantis is struggling to prevent an expanded cannabis ballot initiative passing in Florida. But do voters really consider marijuana when choosing?
While the industry is full of bros who believe they have influence over the election and congress, the numbers don’t add up. It isn’t a make or break issue for most voters. Biden delayed any action on marijuana, despite his promise in 2020, until the last part of this term. Because of this, even if he manages to push things through with the Drug Enforcement Administration, it will be 2025 before any help comes. The GOP nominee’s has come out in support of the Florida initiative against his old foe DeSantis, but leaders in his party are against any legal form of marijuana. House Speaker Mike Johnson (R-LA) has made it very clear cannabis is a no go.
A recent YouGov poll revealed , voters trust the Democratic nominee to handle cannabis laws (27 percent), compared to the GOP candidate (20 percent). But more Trump supporters say marijuana issues are important them (17 percent) than Harris supporters (11 percent). It could mean older conservative believe the GOP will reverse marijuana trends.
The good news is alcohol is a major partner of cannabis having invested over $13 billion in the industry, and they have a longer term relationship with Congress. Constellation, one of the largest players of spirits, wine and beer, made $22 billion in revenue last year compared to the $33 billon the entire marijuana raked in.
Does the industry have a say in the election, absolutely via support, donation and campaigns. But on average, marijuana is not a major issue for most voters.
Presidential candidates relationship with the marijuana industry has involved – now she wants to deliver the winning goal.
The cannabis industry has been nervously waiting for some federal action to let the industry move to the next level. While consumer use is growing and taking a bite out of the alcohol industry, federal resections have put a significant hold on the profitability and growth of cannabis. President’s Biden made a promise to support the industry in 2020, but waited until 2023 to make a move with no noticeable action taking place until 2025. The Drug Enforcement Administration (DEA) is making an announcement on rescheduling in the first part of December, after the election. House Speaker Mike Johnson (R-LA) has leaned in the DEA not to reschedule and made it clear he firmly opposes cannabis. This would go against all precedents as both the Food and Drug Administration and Health and Human Service has said it should be done.
There will be a new president and a new set of rules in December, and the DEA will be watching the political winds. So what is Kamala’s Harris Take on legalizing cannabis? With almost 90% of the country believing it should be legalized in some forms and groups like the American Medical Association, AARP, and the American College of Physicians supporting it, it is not a hot pototo, except for a few in power.
The latest take is Harris proposed legalizing marijuana nationally for recreational use and ensuring Black entrepreneurs have access to the growing cannabis industry. She made the announcement while in California. She has become the first sitting vice president to encourage legalizing it and has become a public champion. This is more open and aggressive than the current Biden administration’s approach. During a wide-ranging conversation on the podcast “All the Smoke” with former NBA stars Stephen Jackson and Matt Barnes, Harris expressed her belief that marijuana should be legalized.
Harris stated, “I believe we have reached a moment where it is crucial to recognize that we need to legalize it and cease the criminalization of this activity.” She emphasized her conviction that individuals “should not face incarceration for using marijuana”
Harris has been critical of the current federal classification of marijuana. During a White House roundtable, she pointed out the absurdity of cannabis being considered as dangerous as heroin and more dangerous than fentanyl under current law. During her 2020 presidential campaign, she expressed support for marijuana legalization and admitted to having used it herself in the past. This shift from her earlier career as a prosecutor demonstrates a changing perspective on cannabis policy.
The $23+ billion industry is full of mom and pop businesses. Democrats have been traditionally been more of ally to the industry. Republican blocked SAFE Banking for 7 times and then the GOP Speaker coup ended any chance for movement last year. Some marijuana industry leaders don’t have faith in Biden or Harris, but the congressional GOP has not be the support to cannabis and the other party.